Why the study?
RCM is associated with poor prognosis and high heart failure incidence in paediatric patients, prompting a need to address frequently asked questions regarding its aetiologies, diagnosis, and management.
This review provides an overview of the aetiologies, clinical presentation, diagnostic process, and prognosis of paediatric restrictive cardiomyopathy.
Supports clinician recognition of paediatric restrictive cardiomyopathy; extends synthesis but leaves open need for prospective validation.
Restrictive cardiomyopathy (RCM) is characterized by restrictive ventricular pathophysiology determined by increased myocardial stiffness. While suspicion of RCM is initially raised by clinical evaluation and supported by electrocardiographic and echocardiographic findings, invasive hemodynamic evaluation is often required for diagnosis and management of patients during follow-up. RCM is commonly associated with a poor prognosis and a high incidence of heart failure, and PH is reported in paediatric patients with RCM. Currently, only a few therapies are available for specific RCM aetiologies. Early referral to centres for advanced heart failure treatment is often necessary. The aim of this review is to address questions frequently asked when facing paediatric patients with RCM, including issues related to aetiologies, clinical presentation, diagnostic process and prognosis.
No takes yet. Share an insight, caveat, or question.
Zampieri et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: